Why RECIST works and why it should stay--reply to counterpoint.

Cancer research

Volumn 72, Issue 20, 2012, Pages 5158-

  Sharma, Manish R ^a   Maitland, Michael L ^b   Ratain, Mark J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); DISEASE COURSE; FOOD AND DRUG ADMINISTRATION; HUMAN; NEOPLASM; PATHOLOGY; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HUMANS; NEOPLASMS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84871853963     PISSN: None     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1988     Document Type: Article

References (0)